These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10333606)

  • 1. [Anti-ulcer drug consumption in Spain].
    Carvajal A; García del Pozo J; del Olmo L; Rueda AM; Alvarez Requejo A
    Aten Primaria; 1999 Mar; 23(4):218-21. PubMed ID: 10333606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Future perspectives of ulcer therapy].
    Garner A
    Ther Umsch; 1992 Nov; 49(11):782-7. PubMed ID: 1475774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of peptic ulcer in the elderly].
    Koop H
    Z Gerontol; 1992; 25(5):304-8. PubMed ID: 1359717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
    Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
    Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
    Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
    Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastroduodenal ulcer disease: therapeutic possibilities].
    Inauen W
    Praxis (Bern 1994); 1995 May; 84(20):585-9. PubMed ID: 7761731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori].
    Kharchenko NV
    Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Helicobacter pylori colonization with omeprazole.
    Fukuda Y
    Scand J Gastroenterol Suppl; 1996; 214():54-5; discussion 57-60. PubMed ID: 8722408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.